| Financial Year |
March 31 2023 |
| Monetary Funds |
271,520,729.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
119,940,679.13 |
| Accounts Receivable |
453,187,468.66 |
| Advances to Suppliers |
23,114,652.46 |
| Other Receivables |
5,145,605.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
270,331,653.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,578,768.20 |
| Total Current Assets |
1,161,947,050.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
4,215,721.50 |
| Fixed Assetes |
161,254,849.03 |
| Under-construction Projects |
55,697,446.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
30,326,551.34 |
| R&D expenses |
-- |
| Goodwill |
179,708,027.34 |
| Long-Term Deferred and Prepaid Expenses |
731,234.86 |
| Deferred Income Tax Assets |
11,453,411.26 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
445,558,213.92 |
| Total Assets |
1,607,505,264.13 |
| Short-Term Loans |
122,717,345.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
29,123,145.40 |
| Accounts Payable |
387,724,577.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,624,994.82 |
| Taxes Payable |
3,694,347.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,483,043.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,518,105.09 |
| Other Current Liabilities |
1,174,596.76 |
| Sub-Total of Current Liabilities |
564,661,890.12 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,854,705.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,733,583.56 |
| Total Liabilities |
579,395,473.68 |
| Paid-In Capital(Or Share Stock) |
173,453,199.00 |
| Capital Surplus |
588,200,385.12 |
| Surplus Reserve |
25,812,399.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
240,643,806.53 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,028,109,790.45 |
| Owner's Equity（Stockholder's Equity） |
1,028,109,790.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,607,505,264.13 |
